Patient Preference Trade-offs for Next-Generation Kidney Replacement Therapies.

Despite an aversion to even a 1% higher risk of death within 5 years, serious infection, and permanent device rejection, patients with kidney failure suggested that they would trade these risks for the benefit of complete mobility.